Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 16,687 $ 13,172
Other receivables 857 1,919
Inventory, net 19 20
Prepaid expenses and other current assets 1,627 1,290
Restricted cash, current portion 63 15
Total current assets 19,253 16,416
Property and equipment, net 2,442 2,411
Goodwill 14,409 14,409
Restricted cash, net of current portion 131 131
Total assets 36,235 33,367
Current liabilities:    
Accounts payable 5,565 2,882
Deferred revenue 111 88
Accrued expenses and other current liabilities 8,273 13,214
Notes payable, current 9,296 5,930
Total current liabilities 23,245 22,114
Notes payable, non-current 10,470 13,486
Royalty obligation 2,000 2,000
Deferred tax liability, net 148 141
Derivative liability 5,010 4,830
Other long-term liabilities 1,629 1,711
Total liabilities 42,502 44,282
Stockholders’ deficit:    
Common stock—$0.001 par value; 200,000,000 shares authorized at March 31, 2023 and December 31, 2022; 13,200,535 and 9,430,535 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 13 9
Additional paid-in capital 307,499 292,900
Accumulated deficit (313,779) (303,824)
Total stockholders’ deficit (6,267) (10,915)
Total liabilities and stockholders’ deficit $ 36,235 $ 33,367